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NADH:ubiquinone oxidoreductase (Complex I, CI) is one of the
major sources of reactive oxygen species (ROS) in mitochondria. ROS
are critically involved in several degenerative diseases like Leigh
syndrome, Leber's hereditary optic neuropathy or Parkinson's disease.
CI-dependent ROS formation occurs at the NADH-site and is driven by
the fully reduced ﬂavin mononucleotide (FMN) rather than the
semireduced FMN radical. The importance of several conserved
amino acids in vicinity to FMN has been shown by structural analysis.
Glu95, Glu97 and Tyr180 in NuoF from Aquifex aeolicus (human
orthologue NDUFV1) are suggested to be involved in electron transfer
from NADH to FMN. Furthermore, Tyr180 is of pathophysiological
relevance indicated by a mutation in a CI-deﬁcient patient (human
orthologue Tyr204).
To investigate the contribution of these amino acids on ROS
formation we used a surrogate model of CI. We coexpressed NuoE and
NuoF from A. aeolicus in Escherichia coli, which results in soluble
NuoEF protein, containing FMN and the Fe–S-clusters N3 and N1a.
Site-directed mutagenesis in NuoF at the positions Glu95, Glu97 and
Tyr180 was used to generate mutant NuoEF. The (mutant) proteins
were investigated by steady state kinetics and redoxtitrations, to
assess the impact of the respective amino acids on ROS formation.
Wild type NuoEF protein generates ROS in a FMNH2-dependent
manner at rates of 110 nmol/min*mg. FMN potential (E0) is−0.320 V
(at pH 7.5) which is comparable to data obtained from CI in E. coli.
Mutations in NuoF critically affect ROS production, e.g. Y180A showed
4-fold higher ROS production, contrasted by Y180L where ROS
production was reduced to 40%. Interestingly, these mutant proteins
show a different behavior in redoxtitrations pointing to a mechanistic
change of ROS production by CI.
These ﬁndings indicate that small changes in the structural
environment of the FMN substantially affect the potential or stability
of different FMN species which affect ROS formation and might have
implications for diseases associated with CI-dysfunction.
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Mitochondrial NADH:ubiquinone oxidoreductase (complex I) is an
L-shaped membrane protein that has a central function in oxidative
phosphorylation. The overall architecture of complex I was determined
using X-ray crystallography, however the mechanism of redox-driven
proton-pumping remains to be elucidated. Electrons are transferred
fromNADH via a chain of Fe–S clusters to reduce ubiquinone bound in a
deep binding pocket that is comprised of the 49-kDa and PSST subunits
of complex I. Iron–sulfur cluster N2, the immediate electron donor for
ubiquinone, resides about 30 Å above the membrane domain. The
binding of the ubiquinone head group is mainly stabilized by
hydrogen bond interactions to the conserved Y144 of subunit 49-
kDa. To investigate the pathway of the hydrophobic tail, ﬁve
chemically modiﬁed ubiquinone derivatives were applied as sub-
strates in enzyme kinetics measured with mitochondrial membranes
of complex I mutants. We concluded from these extended structure/
function analyses that the tail of ubiquinone enters through a narrow
hydrophobic path at the interface between the 49-kDa and PSST
subunits. Furthermore, we identiﬁed several conserved methionines
that seem to form a structural and functional hydrophobic gate to the
active site reminiscent to the M-domains of the signal recognition
particle of the endoplasmic reticulum. To gain further insight into the
architecture of the ubiquinone binding domain, ﬁve amino acids
within the binding pocket of the 49-kDa subunit of Yarrowia lipolytica
were changed by site-directed mutagenesis to match the amino acid
pattern of bovine complex I in this region. We could show that
residue S192 is responsible for the decreased sensitivity of yeast
complex I towards the inhibitor rotenone.
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Complex I or NADH:ubiquinone oxidreductase is the ﬁrst and
largest enzyme of the respiratory chain. Mammalian mitochondrial
complex I is composed of at least 45 subunits with a molecular weight
of 980 kDa. Despite recent progress in structural studies, many
aspects of the regulation of the enzyme are still not clearly
understood. Mammalian enzyme can exist in catalytically active (A)
form and de-active, dormant (D) form. When the turnover of the
enzyme is limited the A-form undergoes reversible de-activation at
physiological temperatures. Until now, the exposure of Cys 39 of the
ND3 subunit after de-activation is the only conformational difference
observed between the A and the D-form, accounting for the
sensitivity of the D-form to SH-reagents [1].
Using two homogenous preparations of bovine heart submito-
chondrial particles containing either the A or the D-form of complex I,
we observed no difference in the proﬁle of respiratory chain enzymes
shown by Blue Native PAGE [2]. Moreover, Cys 39 is accessible for SH-
reagents in the D-form of the enzyme even when complex I is a part
of respiratory chain supercomplexes. To characterise the relative
location of Cys 39 of the ND3 subunit we used internal protease
bromoacetamidobenzyl-EDTA (Fe-BABE)-SH-reagent for differential
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labelling of the A and the D-form of complex I in SMP. After
reduction-induced chemical proteolysis of surrounding proteins by
Fe(II)-chelate, complex I was isolated and subunits were separated by
2D SDS PAGE. In an additional experiment, in order to label primary
amines accessible in both enzyme molecules we used ﬂuorescent
NHS-esters to identify any conformational difference between the A
and the D-form.
The differential labelling of complex I provided new information
on the structural differences between the two forms of the enzyme.
Physiological consequences of de-activation and possible regulatory
modiﬁcations that target one of the forms physiologically are
discussed.
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NADH-ubiquinone oxidoreductase (complex I) is the ﬁrst and the
largest enzyme in the respiratory chain of mitochondria and most
bacteria. Complex I catalyses the transfer of two electrons from NADH
to quinone, coupled to the translocation of about four protons across
the membrane. The mitochondrial enzyme contains 45 different
subunits, while the bacterial enzyme consists of 13–15 different
subunits. Analogues of all conserved bacterial subunits are found in
the mitochondrial enzyme. We study bacterial complex I as a
“minimal” model of the mitochondrial enzyme. It is an L-shaped
assembly, with the hydrophobic arm embedded in the membrane and
the hydrophilic arm protruding into the bacterial cytoplasm.
Recently, we have crystallised the entire complex I from Thermus
thermophilus and determined its architecture by molecular replace-
ment with the structures of the hydrophilic and the hydrophobic
domains [1]. We have now identiﬁed a novel T. thermophilus protein
of about 14.2 kDa, which is not part of the nqo operon. This protein is
present in approximately 50% of the total puriﬁed complex I,
depending on the cell growth and conditions. It does not appear to
be necessary for activity, including proton-pumping. However, it is
essential for crystallisation of the intact complex — it is involved in
crystal contacts, and may also stabilise the junction between the two
main domains, as it binds to the hydrophilic arm close to the
hydrophobic domain. Although there are many chaperones/assembly
factors known for the mitochondrial complex I, this is the ﬁrst case of
a chaperone-like protein described for bacterial complex I.
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Type II or alternative NADH dehydrogenases (NDH-II) are
monomeric enzymes with a molecular mass of ≈50 kDa containing
FAD as the only prosthetic group. They are membrane associated
proteins that catalyse NADH:quinone oxidoreduction but do not
directly contribute to the establishment of the membrane potential.
NDHs-II are present in the three domains of life. In eukaryotes,
their presence has been observed in plants, fungi and protozoa. In
several organisms, especially in pathogenic such as Staphylococcus
aureus, only NDH-II is expressed, which raises the possibility for
rational design of speciﬁc drugs interacting at the level of this
enzyme, which is not present in animal mitochondria. Furthermore,
NDHs-II have been suggested to be used in gene therapy correcting
NADH:quinone oxidoreductase activity in pathologies with
malfunctioning complex I such as neurodegenerative disorders. Thus,
not only for its importance in bioenergetics, but also in other areas
such as health a deep knowledge of NDH-II is demanded.
Although being a simple enzyme and having been isolated for the
ﬁrst time more than thirty years ago, fundamental questions
regarding its structural/functional relation are still unanswered. Its
structure, the substrate binding sites, and its membrane association
mode are still unknown. Also its functional mechanism has to be
investigated, namely concerning the interaction with the substrates
and the way FAD is reduced by NADH and oxidised by the quinone.
In this work conformational changes in NDH-II from Escherichia
coli due to interactions with its substrates (NADH and quinone) were
monitored. For that, changes in the ﬂuorescence of tryptophan
residues in response to ligand binding were followed. In order to
identify the structural elements/motifs involved in substrate interac-
tion, surface enhanced infrared absorption (SEIRA) spectroscopy was
applied.
It was observed that the protein reacts with NADH and with
different quinones promoting the interaction of the ubiquinone
analogue, apparently, more pronounce conformational changes. The
involvement of Trp and Glu/Asn residues in the binding of NADH and
ubiquinone is suggested. The obtained results prompt us to extend
the project to the study of NDHs-II from organisms that synthesize
different quinones. A comparative study showing the differences
between ubiquinone and menaquinone bindings will be showed.
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